1806-54-8 Purity
---
If you have any other questions or need other size, please get a quote.
Specification
The molecular formula of Lasofoxifene is C28H31NO2.
The molecular weight of Lasofoxifene is 413.5 g/mol.
Lasofoxifene is described as a member of the class of tetralins with specific substitutions and roles as an antineoplastic agent, cardioprotective agent, estrogen receptor agonist, estrogen receptor antagonist, and bone density conservation agent.
Lasofoxifene is a non-steroidal, naphthalene-derived, third-generation selective estrogen receptor modulator (SERM) with potential antineoplastic and anti-osteoporotic activities.
Upon oral administration, Lasofoxifene selectively binds to estrogen receptors alpha and beta with high affinity, mimicking the effects of endogenous estradiol with varying agonist and antagonist effects in estrogen receptor-expressing tissues.
Lasofoxifene was initially developed by Pfizer as Oporia for the treatment of postmenopausal osteoporosis and vaginal atrophy.
Fablyn, a version of Lasofoxifene, was developed as a result of a research collaboration between Pfizer and Ligand Pharmaceuticals, gaining approval by the European Commission in March 2009.
Lasofoxifene may potentially be useful in the treatment of tumors that have acquired resistance to other estrogen receptor-targeting agents, due to its binding to certain mutant forms of the estrogen receptor.
Some identifiers associated with Lasofoxifene include its CAS number (180916-16-9), UNII (337G83N988), and ChEMBL ID (CHEMBL328190).
The canonical SMILES representation is C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5. The isomeric SMILES representation is C1CCN(C1)CCOC2=CC=C(C=C2)[C@H]3[C@H](CCC4=C3C=CC(=C4)O)C5=CC=CC=C5.